Commonwealth Equity Services Portfolio holdings
AUM
$75.7B
1-Year Return
17%
This Quarter Return
-3.44%
1 Year Return
+17%
3 Year Return
+64.32%
5 Year Return
+107.58%
10 Year Return
+207.41%
AUM
$48.3B
AUM Growth
-$893M
(-1.8%)
Cap. Flow
+$1.05B
Cap. Flow
% of AUM
2.18%
Top 10 Holdings %
Top 10 Hldgs %
18.23%
Holding
3,996
New
165
Increased
1,895
Reduced
1,606
Closed
171
Top Buys
| 1 |
iShares Russell Top 200 Growth ETF
IWY
|
$94.7M |
| 2 |
Capital Group Growth ETF
CGGR
|
$87.5M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
$73.9M |
| 4 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
$48.8M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
$43M |
Top Sells
| 1 |
iShares S&P Mid-Cap 400 Value ETF
IJJ
|
$27.1M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$24.6M |
| 3 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
$21.8M |
| 4 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
$19.2M |
| 5 |
iShares Core Dividend Growth ETF
DGRO
|
$19M |
Sector Composition
| 1 | Technology | 11.15% |
| 2 | Financials | 5.39% |
| 3 | Healthcare | 4.51% |
| 4 | Consumer Discretionary | 4.27% |
| 5 | Industrials | 3.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3701
Sangamo Therapeutics
SGMO
$165M
| $30K | ﹤0.01% |
50,296
+4,436
| +10% | +$2.65K |
|
3702
AXT Inc
AXTI
$143M
| $29K | ﹤0.01% |
12,156
-311
| -2% | -$742 |
|
3703
C4 Therapeutics
CCCC
$194M
| $29K | ﹤0.01% |
15,471
+61
| +0.4% | +$114 |
|
|
EMX
3704
EMX Royalty
EMX
$444M
| $29K | ﹤0.01% |
16,019
-726
| -4% | -$1.31K |
|
3705
X4 Pharmaceuticals
XFOR
$78.6M
| $29K | ﹤0.01% |
892
+142
| +19% | +$4.62K |
|
3706
Puma Biotechnology
PBYI
$253M
| $28K | ﹤0.01% |
10,749
| – | – |
|
3707
Quantum-Si Incorporated
QSI
$219M
| $28K | ﹤0.01% |
+16,774
| New | +$28K |
|
|
AFMD
3708
DELISTED
Affimed
AFMD
| $27K | ﹤0.01% |
5,620
-250
| -4% | -$1.2K |
|
|
FLNT
3709
Fluent
FLNT
$53.1M
| $27K | ﹤0.01% |
10,045
| – | – |
|
3710
Seres Therapeutics
MCRB
$169M
| $26K | ﹤0.01% |
+552
| New | +$26K |
|
3711
Pyxis Oncology
PYXS
$118M
| $26K | ﹤0.01% |
+12,950
| New | +$26K |
|
|
ADAP
3712
Adaptimmune Therapeutics
ADAP
$10.9M
| $25K | ﹤0.01% |
31,875
| – | – |
|
3713
Atossa Therapeutics
ATOS
$102M
| $25K | ﹤0.01% |
33,345
-1,260
| -4% | -$945 |
|
3714
ESS Tech
GWH
$19.6M
| $25K | ﹤0.01% |
882
-4,231
| -83% | -$120K |
|
3715
Aqua Metals
AQMS
$5.86M
| $24K | ﹤0.01% |
107
| – | – |
|
|
RGLS
3716
DELISTED
Regulus Therapeutics
RGLS
| $24K | ﹤0.01% |
17,500
| – | – |
|
|
TGB
3717
Taseko Mines
TGB
$1.05B
| $24K | ﹤0.01% |
18,695
| – | – |
|
3718
Venus Concept
VERO
$4.24M
| $24K | ﹤0.01% |
1,129
| – | – |
|
3719
Dare Bioscience
DARE
$29M
| $23K | ﹤0.01% |
4,111
-21
| -0.5% | -$117 |
|
|
DBVT
3720
DBV Technologies
DBVT
$245M
| $23K | ﹤0.01% |
1,670
| – | – |
|
|
EGIO
3721
DELISTED
Edgio, Inc. Common Stock
EGIO
| $23K | ﹤0.01% |
+661
| New | +$23K |
|
|
CYBN
3722
Cybin
CYBN
$159M
| $22K | ﹤0.01% |
1,087
| – | – |
|
3723
Gevo
GEVO
$404M
| $22K | ﹤0.01% |
18,536
-800
| -4% | -$950 |
|
|
OGI
3724
Organigram Holdings
OGI
$221M
| $22K | ﹤0.01% |
16,847
-6,108
| -27% | -$7.98K |
|
|
OTLY
3725
Oatly Group
OTLY
$524M
| $22K | ﹤0.01% |
1,241
-478
| -28% | -$8.47K |
|